Our article on preconception/preimplantation screening human embryos for pathogenic variants & mutations with #WGS https://t.co/jYiH3uA2lK #genome#genetics
📢 Exciting News! 🚀 GenEmbryomics, a leading medical genetics company, is pursuing a listing on a US national stock exchange. They've engaged WallachBeth Capital as their financial advisor and partner. Stay tuned for updates on this journey!
https://t.co/klD0uG9OGk
Our latest paper on developing polygenic risk scores for cardiovascular diseases and type 2 diabetes.
https://t.co/E6SFRPMTFE
@PLOSONE@Gene_type@NicholasMMurphy
Our paper in @Epidemio_Infect using the fabulous @LifelinesNL resource has now been published.
Validation of a clinical and genetic model for predicting severe COVID-19 https://t.co/ZsxS5pSLTl
@NicholasMMurphy
This is Maeve with her Mum Sarah. Maeve and her family inspired the landmark Maeve’s Law for Mitochondrial Donation. Maeve’s Law has just passed the Senate 37-17 and will now become law. It is globally leading mitochondrial legislation to give hope to families across Australia.
Artesian completed 9 #VC investments in September - welcome to the new portfolio companies, and power-on to those receiving follow-on:
https://t.co/9PqlQgKsI4
Last chance to apply – the 2021 MedTech Actuator Menzies Scholarships close this Friday!
Join the next cohort to learn about entrepreneurship and commercialisation in #MedTech, #BioTech and #HealthTech.
Apply today and transform your impact – https://t.co/00carcwC4R
Fees for publishing start from about US$800 and can reach over US$11,000
Salaries of researchers in developing world range from US$350 to about US$3,000
Waiver systems ‘too complex and bureaucratic’
Open access ‘excludes’ developing world scientists https://t.co/TxAVc4xQcu
.@DeadlyScience provides #science books & early reading material to remote schools in Australia – & has so far shipped 16K+ books & 500 telescopes to 110+ schools with more to come. Support the next gen of First Nations scientists at https://t.co/8oyuaczTJG @corey_tutt#STEMM